LOS ANGELES--(BUSINESS WIRE)--SiDMAP, LLC (www.sidmap.com), a privately held life-science company that provides metabolomics testing and biomarker development services to the pharmaceutical and biotechnology industries and the biomedical research community, announced today the signing of new contracts with two of Japan’s leading pharmaceutical companies. With these new Japanese contracts, SiDMAP now serves industry clients and academic customers in North America, Europe, and Asia.
